ArticleMolecular cancer therapeutics2012

Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents.

Sagar Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.